Rong Wang, PhD^1*, Rory M. Shallis, MD², Jan Philipp Bewersdorf, MD^3*, Amer M. Zeidan, MBBS, MHS⁴, Scott F. Huntington, MD, MPH⁵, Xiaomei Ma, PhD^6* and Nikolai A. Podoltsev, MD, PhD⁷

¹Yale University School of Public Health, New Haven, CT
²Yale Cancer Center, West Haven, CT
³Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
⁴Yale University School of Medicine and Yale Cancer Center, New Haven, CT
⁵Hematology, Yale University School of Medicine, New Haven, CT
⁶Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT
⁷Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Madison, CT

Esther Natalie Oliva, MD¹, Suman Kambhampati, MD^2,3*, Albert Oriol^4*, Ignazia La Torre^5*, Barry Skikne, MD^6,7*, C.L. Beach, PharmD^7*, Keshava Kumar, PhD^7*, Qian Dong, DrPH^7*, Clara Chen^7*, Sandip Ranjan, MTech^8*, Zephirin Kiendrebeogo, Msc, PMP^9* and Thorsten Braun, MD, PhD¹⁰

¹Division of Hematology, Azienda Ospedaliena (B-M-M), Bologna, Italy
²VA Medical Center, Kansas City, MO
³Sarah Cannon at Research Medical Center, Kansas City, MO
⁴Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁵Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
⁶Kansas University Medical Center, Kansas City, KS
⁷Bristol Myers Squibb, Princeton, NJ
⁸SmartAnalyst India Pvt. Ltd, Gurgaon, India
⁹SmartAnalyst, Inc., New York, NY
¹⁰Hopital Avicenne, AP-HP, Paris XIII University, Bobigny, France

Vanessa E Kennedy, MD¹, Theresa Keegan, PhD, MS², Qian Li, MS^3*, Fran Maguire, PhD, MPH^4* and Lori Muffly, MD, MS⁵

¹University of California- San Francisco, San Francisco, CA
²University of California, Davis, Sacramento, CA
³Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
⁴California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Health, Institute for Population Health Improvement, Davis, CA
⁵Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA

Ankita Kapoor, MD¹, Mehul P. Patel, MD², Arjun Khunger, MD^3*, Mazen Jizzini, MD^4*, Mohammad Ammad Ud Din, MD^1*, Simrat Gill, MD^1*, Samar Nasir, MD^4*, Dharmini Manogna, MD¹, Roopali Goyal Gandhi, MD^1*, Nikhil Agrawal, MD^5*, Syed Ather Hussain, MD^1*, Pulkit Gandhi, MD^6* and Saad Jamshed, MD²

¹Division of Internal Medicine, Rochester General Hospital, Rochester, NY
²Lipson Cancer Institute, Rochester General Hospital, Rochester, NY
³Division of Internal Medicine, Memorial Hospital West, Pembroke Pines, FL
⁴Division of Internal Medicine, University at Buffalo, Buffalo, NY
⁵Division of Cardiovascular Diseases, University of Texas at Houston/MD Anderson Cancer Center, Houston, TX
⁶Rochester General Hospital, Rochester, NY

Gabriel Tremblay, DBA, MSc, BS^1*, Patrick Daniele^1*, Mike Dolph, MSc BHSc^1*, Timothy J. Bell^2*, Geoffrey Chan, MD³, Andrew Brown, PhD^2* and Joseph C Cappelleri, PhD, MPH, MS^2*

¹Purple Squirrel Economics, Montreal, QC, Canada
²Pfizer Inc., New York, NY
³Pfizer Inc, Collegeville, PA

Peter Paschka, MD¹, Hervé Dombret, MD^2*, Xavier Thomas, MD, PhD³, Christian Recher, MD, PhD⁴, Sylvain Chantepie, MD^5*, Pau Montesinos Fernandez, MD, PhD^6,7*, Evelyn Acuña-Cruz, MD^6*, Paresh Vyas, MRCP, FRCP, FRCPath⁸, Karl-Anton Kreuzer, MD^9*, Michael Heuser¹⁰, Klaus H. Metzeler, MD¹¹, Michael Dennis, MD¹², Bruno Quesnel, MD, PhD^13*, Hunault-Berger Mathilde, MD, PhD^14*, Mohamad Mohty, MD, PhD¹⁵, Arnaud Pigneux, MD, PhD^16*, Stephane De Botton, MD, PhD^17*, Daniela Weber, MSc^18*, Konstanze Dohner, MD¹, Gary Milkovich, PharmD^19*, John Reitan, PharmD^19*, Sarah C MacDonald, SD^20*, Deborah Casso, MPH^21*, Michael Storm, MSc^22*, Hua Liu, PhD^22*, Stephanie M. Kapsalis, BS^22*, Eyal C. Attar, MD^22*, Thomas Winkler, MD^23* and Hartmut Döhner, MD^1*

¹Universitätsklinikum Ulm, Ulm, Germany
²Hôpital Saint-Louis, Paris, France
³Centre Hospitalier Universitaire de Lyon-Sud, Lyon, France
⁴Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse, Toulouse, France
⁵Institut d’Hématologie de Basse-Normandie, Centre Hospitalier Universitaire de Caen, Caen, France
⁶Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁷CIBERONC, Instituto Carlos III, Madrid, Spain
⁸University of Oxford, Oxford, United Kingdom
⁹Uniklinik Köln, Köln, Germany
¹⁰Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹¹Department of Hematology and Oncology, University of Munich, Munich, Germany
¹²The Christie NHS Foundation Trust, Manchester, United Kingdom
¹³Centre Hospitalier Régional Universitaire de Lille, Lille, France
¹⁴CRCINA Centre Hospitalier Universitaire d'Angers, Angers, France
¹⁵Saint Antoine Hospital, Paris, France
¹⁶Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
¹⁷Institut Gustave Roussy, Villejuif, France
¹⁸Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany
¹⁹RJM Group, LLC, Washington, DC
²⁰IQVIA, Kirkland, QC, Canada
²¹IQVIA, Seattle, WA
²²Agios Pharmaceuticals, Inc, Cambridge, MA
²³Agios Pharmaceuticals, Inc., Cambridge, MA